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	 	 	This	 study	 involved	 experimental	 challenges	 to	A. fumigatus	 and	degraded	PVC	 flooring	material	

























	 	 	On	 the	 next	morning	 after	 the	PVC	challenge,	 the	 subjects	 reported	 significantly	more	 frequently	
respiratory	tract	symptoms	compared	to	control	exposure	(p=0.029).	The	PVC	challenge	did	not	affect	
the	levels	of	inflammatory	markers	or	lung	functions.	
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problems	 both	 in	 residential	 and	 occupational	 environments	 (Bornehag	 et	 al.	 2001).	











	 	 	 In	 addition	 to	 the	 adverse	 effects	 caused	 by	 the	microbial	 exposure	 as	 such,	 the	
microbial	growth	in	building	materials	may	lead	to	degradation	of	polyvinyl	chloride	





	 	 	As	stated	before,	exposure	 to	 indoor	air	microbes	 is	associated	with	 inflammatory	
respiratory	 diseases	 and	 symptoms.	 Thus,	 an	 assessment	 of	 airway	 inflammation	




inflammation.	 For	 example,	 among	 asthmatics,	 the	 FE
NO





























































(Kurup	 et	 al.	 2000;	 2002).	 It	 has	 been	 reported	 that	 e.g.	Alternaria, Cladosporium, 




that	mediate	 the	 adverse	 health	 effects	 of	 indoor	 air	microbes	 and	 that	 non-allergic	
inflammatory	 responses	 seem	 to	 play	 an	 important	 role.	Elevated	 serum	 fungal	 IgG	
antibody	levels	have	been	found	in	farmers	with	extensive	occupational	mould	exposure	
(Erkinjuntti-Pekkanen	et	al.	1999).	In	a	previous	study,	which	examined	teachers	with	






not	to	the	other	moulds	including	Aspergillus fumigatus, A. versicolor, Cladosporium 
cladosporioides, Fusarium oxysporum, Sporobolomyces salmonicolor, Stachybotrys 
















start	 to	grow	on	 the	wet	material.	The	microbes	 that	can	be	considered	as	 indicators	
of	 a	 moisture	 problem	 are	 mostly	 moulds	 but	 also	 yeasts	 and	 bacteria	 are	 found	



















cell	 wall	 constituent	 of	 moulds,	 has	 also	 been	 shown	 to	 have	 immunomodulatory	
properties	in	airway	inflammation	(Strong	et	al.	2002).	
	 	 	Many	of	 the	filamentous	fungal	species	found	in	damp	buildings	produce	harmful	
secondary	metabolites	 such	as	mycotoxins	 (Bennet	 and	Klich	2003).	Animal	 studies	
have	reveald	 that	mycotoxins	evoke	both	cytotoxic	and	 inflammatory	changes.	They	
also	disrupt	cellular	structures	and	interfere	with	vital	cellular	processes	such	as	RNA	
Figure 1. Microscopic view of Aspergillus fumigatus showing typical columnar, 
uniseriate conidial heads (© Dr David Ellis, School of Molecular and Biomedical 
Science, The University of Adelaide, Australia). 
21
and	 DNA	 synthesis	 (Jarvis	 and	Miller	 2004).	 In	 addition	 to	 mycotoxins,	 fungi	 can	










   Aspergillus fumigatus was	investigated	in	this	study	and,	therefore,	it	will	be	examined	
in	more	detail.	
   A. fumigatus	 is	a	fungus	 that	has	been	 isolated	frequently	from	moisture-damaged	
buildings	in	and	its	presence	linked	with	a	variety	of	upper	and	lower	airway	symptoms	
in	the	occupants	(Hyvrinen	et	al.	1999).	Within	the	Aspergillus	spp,	A. fumigatus,	a	

















innate	 cellular	 system	 (alveolar	 macrophages,	 neutrophils)	 which	 is	 responsible	 for	
killing	of	the	conidia.	Conidial	dihydroxynaphthalene-melanin	has	been	recognized	as	
a	virulence	factor	of	A. fumigatus	and	it	is	present	on	the	conidial	surface.	On	the	other	









both	Th1-	 and	Th2-type	 responses	 evoked	 by	A. fumigatus	 (Schuh	 et	 al.	 2003).	On	
the	other	hand,	it	has	been	reported	that	fungal	allergy	(including	A. fumigatus)	is	rare	
among	symptomatic	 subjects	exposed	 to	 indoor	air	microbes	of	a	moisture-damaged	


































	 	 	Wieslander	et	al.	 (1999)	and	Norbck	et	al.	 (2000)	have	studied	nasal,	ocular	and	
asthmatic	 symptoms	 in	 relation	 to	 building	 dampness	 and	 the	 degradation	 of	 PVC	
flooring	 material	 among	 87	 workers	 of	 four	 geriatric	 hospitals.	According	 to	 their	
studies,	release	of	the	DEHP	from	PVC	flooring	causes	conjunctival	and	nasal	irritation	
and	 increases	asthma-like	symptoms	 in	 the	exposed	subjects.	They	also	detected	 the	
PVC	degradation	product	2-ethylhexanol	in	indoor	air	samples.
			Jaakkola	et	al.	(1999;	2000)	have	published	studies	on	the	problems	associated	with	
plastic	 materials	 at	 home	 and	 how	 this	 impacts	 on	 the	 respiratory	 health	 of	 young	
children.	They	concluded	that	the	chemical	emissions	from	PVC	materials	into	indoor	
air	 could	 cause	 adverse	 respiratory	 effects.	Bornehag	 et	 al.	 (2004)	 described	 a	 dose	
response	relationship	among	children	between	asthma	prevalence	and	the	concentrations	






























Aspergillus fumigatus is	 a	 well-known	 indicator	 microbe	 of	 mould	 damages	 (Hyv

























body	 has	 been	 exposed	 to	 harmful	 antigens	 and,	 consequently,	 represents	 a	 specific	
















































and	peritoneal	macrophages)	 and	 skin	 (histiocytes,	Langerhans’s	 cell).	Macrophages	
have	 also	 been	 classified	 according	 to	 how	 they	 are	 activated.	 Classically	 activated	
macrophages	 exhibit	 a	 Th1-like	 phenotype	 promoting	 inflammation,	 extracellular	
matrix	(ECM)	destruction	and	apoptosis.	Instead,	alternatively	activated	macrophages	




contain	 lysozyme,	myeloperoxidase	 (MPO)	 and	 human	 neutrophil	 lipokalin	 (HNL).	
Neutrophils	 are	 involved	 in	 acute	 inflammatory	 responses,	 acting	 as	 a	 first	 line	 of	
defence	against	invading	micro-organisms.	In	the	inflammatory	context,	the	neutrophils	
are	known	 to	produce	proinflammatory	cytokines	 (TNF-α	and	IL-1β),	CC	and	CXC	
chemokines,	 macrophage	 inflammatory	 protein	 (MIP-1α)	 and	 angiogenic	 factors	
(Kasama	et	al.	2005).
			Eosinophil	granulocytes	are	produced	in	bone	marrow	and	they	are	normally	found	
in	 peripheral	 blood	 and	 gut	 lining.	 Eosinophils	 are	 essential	 mediators	 of	 allergic	
inflammation	 and	 increased	 eosinophil	 levels	 have	 been	 detected	 in	 atopic	 disease	
such	 as	 asthma	 and	 allergic	 rhinitis	 (serum,	 sputum)	 and	 also	 in	 parasitic	 infections	
(Keatings	and	Barnes	1997).	Hypereosinophilic	syndrome	(HES)	is	a	rare	disorder	that	
is	 characterized	 by	 persistent	 and	marked	 eosinophilia	 combined	with	 organ	 system	








CD4	 cells	 are	 subgrouped	 to	Th1	 cells	 producing	 IFN-γ	 and	Th2	 cells	 inducing	 the	




of	 cells.	 Epithelial	 and	 inflammatory	 cells	 in	 the	 nasal	 mucosa	 can	 secrete	 several	











adhesion	molecules	 and	 chemokines	 and	 enhances	 the	 production	 of	NO	 (Barnes	 et	
al.	1998;	Opal	et	al.	2000).	 IL-1β	 stimulates	 the	production	of	TNF-α	which	 is	also	
a	 proinflammatory	 cytokine	 (Yoshimura	 et	 al.	 2003).	 In	 a	 similar	manner	 to	 IL-1β,	
TNF-α	stimulates	the	expression	of	endothelial	adhesion	molecules	but	also	stimulates	







	 	 	 IL-6	 is	 also	 a	proinflammatory	 cytokine	but,	 on	 the	other	hand,	 it	 can	 inhibit	 the	













IFN-γ	 are	 called	Th1	cells	 and	 those	producing	 IL-4	 are	designated	Th2	cells.	Mast	
cells	can	generate	IL-4,	while	the	natural	killer	cells	are	an	important	source	of	IFN-γ.	
IL-4	promotes	the	Th2-type	response	and	it	is	connected	to	allergy	and	atopic	disease.	
In	addition,	 the	Th2-type	response	 including,	 the	elevated	IL-4	levels,	dominates	 the	
immune	 response	 in	A. fumigatus	 induced	 diseases	 such	 as	 pulmonary	 aspergillosis	
(Schuh	et	al.	2003).	Elevated	IL-4	levels	in	NAL	have	been	found	in	association	with	
occupational	mould	exposure	(Roponen	et	al.	2001).	Th1-type	cytokine	IFN-γ	inhibits	







detected	 in	 several	 respiratory	 disorders	 e.g.	 in	 rhinovirus	 infections	 (Ferreira	 et	 al.	
2002).
2.5	Non-invasive	methods	for	airway	inflammation	assessment
	 	 	Several	non-invasive	methods	have	been	developed	 for	assessing	 respiratory	 tract	
inflammation.	 In	 this	 study,	 fractional	 exhaled	 (FE
NO
)	 and	 nasal	 (FN
NO
)	 nitric	 oxide	
(NO)	measurements,	 lung	 function	 tests	 including	 spirometry	 and	diffusion	 capacity	
(DLCO)	 and	 the	 assessment	 of	 cytokine	 concentrations	 in	 nasal	 lavage	 fluid	 (NAL)	












analyses	 (Fontjin	 et	 al.	 1970).	 	 FE
NO








data	 show	 that	 the	 normal	 FE
NO






























































	 	 	 It	has	been	stated	that	FE
NO
	levels	 increase	in	asthma	and	decline	from	these	high	








flow	 values	 and	 eosinophilic	 inflammation	 as	 determined	 in	 blood,	 bronchoalveolar	
lavage	(BAL)	and	sputum	(Fabio	et	al.	2004).	
	 	 	 The	 role	 of	 FE
NO
	 in	 COPD	 is	 conflicting.	 Current	 smokers	 with	 severe	 COPD	
(particularly	 in	 combination	 with	 cor	 pulmonale)	 show	 lower	 FE
NO









	 	 	Other	 disorders	 associated	with	 increased	FE
NO
	 levels	 are	 rhinitis,	 bronchiectasis,	



































nasal	 polyposis	 (Selimoglu	 2005).	However,	 according	 to	 Jorissen	 et	 al.	 (2001),	 the	
FN
NO
	 levels	 in	 people	 suffering	 from	 an	 upper	 airway	 infection	 did	 not	 differ	 from	



















	 	 	Variation	 in	 cell	 counts,	NO	and	 cytokine	 levels	 of	NAL	has	 been	 evaluated	 and	
there	are	differences	between	 the	genders.	For	example,	baseline	cytokine	 levels	are	
significantly	 higher	 in	 males	 compared	 to	 females.	 However,	 the	 low	 intra-patient	












building	 (Gunnbjrnsdottir	et	al.	2003).	 	Conversely,	 reduced	FEV1	and	FVC	 levels	










































































was	 excluded	 as	 baseline	 cytokine	 levels	 in	 NAL	 are	 significantly	 higher	 in	 males	
37













-adrenoreceptor	 agonists,	 leukotriene	 receptor	 antagonists	 and	mast	 cell	 stabilizers	



















et	 al.	 2000;	 Figure	 2).	When	 measuring	 FE
NO
,	 the	 subjects	 performed	 a	 slow	 vital	
























salt	 solution	 (4.5	ml)	 was	 instilled	 through	 a	 heat-softened	 catheter	 into	 the	 nostril	
(Figure	3).	The	subject	held	his	or	her	chin	down	during	the	instillation,	and	held	the	
catheter	in	place	by	pinching	the	nostrils	closed.	The	cartilaginous	bridge	of	the	nose	













	 	 	 Concentrations	 of	 IFN-γ	 (III),	 TNF-α	 (III,	 IV),	 IL-1β	 (III),	 IL-4	 (III,	 IV),	 IL-6	
(III,	 IV)	and	IL-12	(IV)	 in	 the	NAL	supernatant	were	analyzed	by	using	ELISA	kits	
(R&D	Systems™,	Minneapolis,	MN,	USA).	Assays	were	 analyzed	 according	 to	 the	
manufacturer's	 instructions	with	 the	ELISA	microplate	 reader	 (iEMS	Reader	MF™,	
Labsystems,	 Finland)	 at	 a	wavelength	 of	 450	 nm	 by	 comparing	 the	 absorbances	 of	









	 I	 II	 III	 IV
_____________________________________________________________________
Number	of	subjects:	 21	 28	 27	 10
Age	years:	 38	 45	 45	 43
(range)	 (22-57)	 (27-60)	 (27-60)	 (28-53)
Gender:
Female	 14	 27	 27	 3
Male	 7	 1	 0	 7
Smoking:
Current	smokers	 0	 1	 1	 2




Storage	mites	 	 10	 9
Moulds	 	 1#	 1#
Doctor-diagnosed
asthma:	 0	 0	 0	 5
Occupational	mould	 	 13	 13
exposure:






	 I	 II-III	 IV
Criterion
_____________________________________________________________________
Smoking	 All	the	subjects	 Prohibited	during	 Prohibited	during
	 non-smokers	 the	study	period	 the	study	period
Vigorous	Exercise	 Prohibited	during	 Prohibited	during	 Prohibited	during
	 the	study	period	 the	study	period	 the	study	period
Occurrence	of	 at	least	6	weeks	 at	least	6	weeks	 at	least	6	weeks	
previous	respiratory	 prior	to	the	study	 prior	to	the	study	 prior	to	the	study
tract	infection
Regular	medication	 Prohibited	 Prohibited	 Prohibited	3	days
	 	 	 before	the	study
Short-acting	β
2
-agonists	 Prohibited	during	 Prohibited	during		 Prohibited	6	hours






































Figure 3. Collection of a NAL sample.





















Denmark).	The	prick	 tests	 included	14	common	environmental	 allergens	 (two	house	
dust	mites	 (Dermatophagoides farinae and Dermatophagoides pteronyssinus),	 birch,	
alder,	meadow	 fescue,	 timothy,	meadow	grass,	mugwort,	 dandelion,	 horse,	 dog,	 cat,	
cow	 and	 natural	 rubber),	 three	 storage	mites	 (Lepidoglyphus destructor, Acarus siro 
and	 Tyrophagus putrescentiae) and	 13	 moulds	 (Alternaria alternata, Cladosporium 
herbarum, Aspergillus fumigatus, Aspergillus versicolor, Aureobasidium pullulans, 
45
Botrytis cinerea, Chaetomium globusum, Geotrichium candidum, Mucor racemosus, 

















	 	 	 From	 serum	 samples,	 total	 IgE	 (IU/L)	 was	 determined	 by	 EIA	 (Immulite	 total	
IgE®,	 Diagnostic	 Products	 Corporation,	 Los	 Angeles,	 CA,	 USA),	 ECP	 (IU/L)	 by	


















significant	 (Faul	 et	 al.	 1999).	 The	 coefficients	 of	 variation	were	 also	 calculated.	 In	















placebo	challenges	and	Wilcoxon	signed	 rank	 test	was	used	 to	compare	 the	changes	
between	active	agent	and	placebo	inhalations.	Logarithmic	transformations	were	used	





for	 both	A. fumigatus	 and	 placebo	 challenges.	Despite	 standard	 transformations,	 the	
normal	distribution	of	the	cytokine	data	was	not	achieved.	Therefore,	the	non-parametric	
Wilcoxon	 signed	 rank	 test	was	used	 to	 compare	 the	 changes	of	 cytokine	production	
between	the	challenges	(A. fumigatus	vs.	placebo)	at	different	time	points	(before	the	
47












































	 	 	Each	 subject	 underwent	 randomly	 two	 challenges	where	 they	 inhaled	Aspergillus 
fumigatus	or	placebo	solution	via	a	nebulizer	(Spira	elektro	2	flowmeter™,	Respiratory	




























	 	 	 In	study	III,	 the	NAL	samplings	for	cytokine	(IFN-γ,	TNF-α,	 IL-1β,	 IL-4	and	IL-





4).	The	ventilation	was	adjusted	 so	 that	 the	carbon	dioxide	concentration	during	 the	
exposure	 session	 in	 the	 chamber	 stayed	 below	 1000	 ppm.	 The	 chamber	 was	 tested	
to	ensure	it	was	tight	and	clean	(total	volatile	organic	compounds	(TVOC)	below	10	
µg/m3).	The	exposure	material	used	in	the	exposure	tests	 in	the	chamber	was	a	PVC	
flooring	material	 recently	 removed	 from	an	office	where	 the	occupants	had	 suffered	
respiratory	and	dermal	irritation	symptoms	related	to	degrading	PVC.	The	area	of	this	









laminate	 bags	 have	 been	 used	 in	 collecting	 air	 samples	 such	 as	 sulphur	 oxides	 and	























afternoon.	 In	 the	 autumn,	 the	 afternoon	 values	 of	 FN
NO





	 levels	was	 significant	 in	 the	mornings	but	 not	 in	 the	 afternoons	
(r=0.868,	r=0.543,	respectively,	Table	4B,	Figure	5A).



















































	 Mornings	 Afternoons	 n	 r	 p	 CoV	(%)
	 127.1±28.9	 149.2±40.2	 54	 0.565	 0.005	 11.0
FE
NO
	 Mornings	 Afternoons	 n	 r	 p	 CoV	(%)









	 1st	day	 2nd	day	 n	 r	 p	 CoV	(%)
Morning	 121.4±37.5	 119.8±29.6	 21	 0.868	 0.000	 8.1
Afternoon	 136.0±51.5	 144.2±45.0	 21	 0.543	 0.004	 17.5
FE
NO
	 1st	day	 2nd	day	 n	 r	 p	 CoV	(%)
Morning	 14.6±6.7	 14.2±5.1	 21	 0.784	 0.000	 16.1
Afternoon	 16.7±7.2	 16.8±5.6	 21	 0.779	 0.000	 14.7








	 1st	week	 2nd	week	 n	 r	 p	 CoV	(%)
Morning	 121.4±37.5	 128.0±32.1	 18	 0.637	 0.001	 12.3
Afternoon	 136.0±51.5	 151.4±48.1	 18	 0.781	 0.000	 12.4
FE
NO
	 1st	week	 2nd	week	 n	 r	 p	 CoV	(%)
Morning	 14.6±6.7	 15.4±7.3	 18	 0.738	 0.000	 19.4
Afternoon	 16.7±7.2	 19.4±8.5	 18	 0.560	 0.005	 17.0




	 (ppb)	 in	 autumn,	winter	 and	 summer	
mornings	(mean±SD).
	 autumn	 winter	 summer	 n	 r	 p	 CoV	(%)
FN
NO
	 121.4±37.5	 133.5±29.7	 138.1±47.6	 17	 0.624	 0.000	 21.0
FE
NO
	 14.6±7.2	 16.6±6.4	 17.4±8.0	 17	 0.709	 0.000	 15.7
53
Figure 5. Repeatability of FN
NO
 (A) and FE
NO
 (B) measurements performed in consecutive 
mornings 24h apart visulized by Bland-Altman plots. It is anticipated that 95% of the 
differences between measures will be < 2 SD.
Figure 6. Repeatability of FN
NO
 (A) and FN
NO
 (B) measurements collected one week 
apart in the mornings expressed by Bland-Altman plots. It is anticipated that 95% of the 






	 	 	On	the	next	morning	after	 the	challenges,	 the	subjects	 reported	significantly	more	
frequently	 airway	 symptoms	 after	 the	 A. fumigatus challenge	 compared	 to	 placebo	
inhalation	 (57	%	 vs.	 25	%,	 respectively,	 p=0.014,	 n=27).	 Symptoms	 of	 both	 upper	
(blocked	nose,	 rhinorrhea,	 sneezing)	 and	 lower	 (cough,	 phlegm)	 airways	were	more	















































	 	 	 FEV1	 decreased	 significantly	 during	 the	A. fumigatus	 (3.04-2.94	 l,	 p=0.013)	 and	









Figure 7. The changes in mean levels of a) FE
NO
 (all of the subjects) and b) FN
NO
 
after A. fumigatus (—) and placebo (…) challenges (measured before and at 3, 6 and 
24 hours later). There was a significant difference between the challenges in FE
NO
 















	 	 	Mean	 levels	 of	 IL-1β	 in	NAL	 increased	 time-dependently	 after	 the	A. fumigatus	
challenge	with	the	peak	concentrations	being	achieved	24	hours	after	the	challenge.	In	
contrast,	IL-1β	levels	decreased	after	the	placebo	challenge	compared	to	the	baseline.	
When	 all	 the	 subjects	 were	 examined	 as	 a	 single	 group,	 the	 changes	 of	 the	 IL-1β	
levels	 from	 the	baseline	were	 significantly	higher	 both	 at	 6	 (p=0.013)	 and	24	hours	
(p=0.005)	after	the A. fumigatus	challenge	compared	to	the	placebo	(Table	6,	Figure	8).	
At	the	group	level,	significant	differences	in	changes	between	A. fumigatus	and	placebo	
challenges	were	 also	 seen	 in	 the	 control	 group	 at	 6	 (from	baseline	 24.1	 to	 47.9	 pg/
ml	vs.	from	baseline	69.6	to	26.2	pg/ml,	respectively,	p=0.01)	and	24	(from	baseline	
24.1	to	71.7	pg/ml,	from	baseline	69.2	to	22.2	pg/ml,	respectively,	p=0.008)	hours	after	
the	challenges	but	not	 in	 the	other	 study	groups.	 In	addition,	 there	was	a	 significant	
difference	in	baseline	levels	of	IL-1β	between	the	A. fumigatus	and	placebo	challenges	
(Table	6,	p=0.004).
	 	 	 There	was	 an	 increase	 of	 the	 IL-4	 concentrations	 in	NAL	 after	 the	A. fumigatus	
challenge	whereas	the	placebo	challenge	decreased	the	levels	(Table	6).	The	increase	




























significant	 difference	 between	A. fumigatus	 and	 placebo	 challenges	 in	 the	 extent	 of	







	 Mould	exposed	 Atopic	 Controls
Cytokine	 (n=13)	 (n=4)	 (n=10)
_____________________________________________________________________		
TNF-α**	 0.1	(0-0.6)	 0.3	(0-1.0)	 31.4	(0-230)
IL-1β	 19.7	(0-89)	 47.4	(1-150)	 51.5	(5.2-200)
IL-4	 0.4	(0-1.9)	 0.5	(0-1.9)	 14.7	(0-120)
IL-6	 7.2	(0-29.9)	 6.7	(0-18)	 69.3	(1.6-370)





Figure 8. The changes of IL-1 levels from the baseline after the A. fumigatus and 
placebo challenges. There was a significant difference between the challenges measured 




Cytokine	 Challenge	 	 Baseline	 aChange		 bChange
	 	 	 	 6	hours	 24	hours
_____________________________________________________________________		
TNF-α	 A. fumigatus	 3.3	 3.6	 8.2
	 	 	 (0-52.7)	 (-7.7-42.2)	 (-17.5-150)
	 Placebo	 	 11.9	 -3.6	 -3.9
	 	 	 (0-230)	 (-87.4-8.1)	 (-190-46.9)
	 	 p-value	 0.064	 0.121	 0.379
IL-1β	 A. fumigatus	 18.1	 6.7	 23.7
	 	 	 (0-150)	 (-65.7-180)	 (-37.6-520)
	 Placebo	 	 38.3	 -15.3	 -19.0
	 	 	 (0.3-200)	 (-125.1-190)	 (-170-99.1)
	 	 p-value	 0.004	 0.013	 0.005
IL-4	 A. fumigatus	 1.5	 1.0	 1.1
	 	 	 (0-10)	 (-1.3-13)	 (-3.7-21)
	 Placebo	 	 5.8	 -2.9	 -4.1
	 	 	 (0-120)	 (-73.5-3.9)	 (-110-5.6)
	 	 p-value	 0.256	 0.057	 0.099
IL-6	 A. fumigatus	 8.1	 14.0	 8.3
	 	 	 (0-35.3)	 (-32-200)	 (-20.5-220)
	 Placebo	 	 31.1	 -18.4	 -13.2
	 	 	 (0-370)	 (-220-40.8)	 (-300-77.8)
	 	 p-value	 0.143	 0.058	 0.848
IFN-γ	 A. fumigatus	 7.4	 -0.2	 -0.1
	 	 	 (0-16.8)	 (-4.5-6.7)	 (-4-13.7)
	 Placebo	 	 7.5	 -0.2	 -0.3
	 	 	 (0-17.2)	 (-4.2-2.2)	 (-2.9-7.2)
	 	 p-value	 0.411	 1.000	 0.168
_____________________________________________________________________		
Data	presented	as	mean	values	(range)	pg/ml








eosinophils	 in	 the	NAL	were	 seen	 after	 the	 challenges.	Moreover,	 no	 differences	 in	




















	 PVC   Placebo	 p-value
	 flooring__________________
Symptoms	during	the	exposures:
Lower	Airway	 2	(20)	 0	(0)	 0.263
Upper	Airway	 7	(70)	 5	(50)	 0.430
Lower	and	Upper	Airway	 8	(80)	 5	(50)	 0.259
Fatigue	 1	(10)	 1	(10)	 0.737
Skin	 2	(20)	 2	(20)	 0.712
Eye	 3	(30)	 1	(10)	 0.333
Symptoms	on	the	morning	following	the	exposures:
Lower	and	Upper	Airway	 5	(50)	 0	(0)	 0.029
_____________________________________________________________________		
Data	presented	as	n	(%)
Table	 8.	 Cytokines	 (TNF-α,	 IL-4,	 IL-6	 and	 IL-12)	 (mean	 and	 range,	 pg/ml)	 and	




	 After	 Before	 After	 Before	 After
	 holiday	 PVC	 PVC	 control	 control
TNF-α		 179.7	 152.2		 267.2	 103.9	 177.5
	 (0-1208.8)	 (0-749.0)	 (0-1146.8)	 (0-517.6)	 (0-803.0)
IL-4	 51.6	 56.4	 102.9	 39.6	 80.1
	 (0-379.6)	 (0-276.4)	 (0-529.3)	 (0-234.7)	 (0-533.8)
IL-6	 76.9	 71.2	 108.6	 49.3	 106.4
	 (0.2-572.4)		 (0-383.9)	 (0.1-536.1)	 (0.5-278.4)	 (0-525.9)
IL-12	 308.4	 	413.1	 453.2	 171.8	 435.5
	 (0-1863.0)	 (0-2218.1)	 (0-2647.8)	 (0-1027.6)	 (0-2650.9)
NO	 6.8	 4.8	 6.6	 6.1	 4.9
	 (1.7-46.6)	 (1.6-10.1)	 (1.3-18.9)	 (1.0-18.0)	 (1.6-23.4)
62
5.3.2	TVOC	and	2-ethylhexanol	concentrations
	 	 	 Concentrations	 of	TVOC	 and	 2-ethylhexanol	 in	 the	 chamber	 air	 during	 the	 PVC	
challenges	and	TVOC	during	the	control	(ceramic	tiles)	tests	are	shown	in	the	figure	
9.	During	 the	 control	 exposure,	 2-ethylhexanol	 concentrations	were	 very	 low	 in	 the	
chamber	air	(≤	2.4	µg/m3).	The	correlation	between	TVOC	levels	in	exposure	chamber	
and	in	exhaled	breath	samples	during	the	PVC	exposure	is	shown	in	figure	10.	Figure	





Figure 9. Concentrations of TVOCs and 2-ethylhexanol during the PVC exposure and 




Figure 11. Correlation between 2-ethylhexanol concentrations in exposure chamber air 
and in exhaled breath samples during exposure to PVC. R2=0.4792.
Figure 10. Correlation between TVOCs in exposure chamber air and in exhaled breath 






values.	The	 spirometric	 values	 did	 not	 change	 significantly	 during	or	 after	 the	PVC	
challenge,	 neither	 were	 there	 any	 significant	 differences	 in	 lung	 functions	 between	
the	PVC	and	 control	 exposures.	The	baseline	 levels	 of	 lung	 functions	did	not	 differ	
significantly	 in	 asthmatic	 subjects	 or	 smokers	 (including	 current	 and	 ex-smokers)	




















immediately	 after	 exposure	 to	 either	PVC	 flooring	or	 the	 control	material	 and	 there	
were	no	statistically	significant	differences	in	the	cytokine	concentrations	between	the	
challenges.	No	 changes	were	 detected	 in	NO	 concentrations	 of	NAL	 after	 the	 PVC	
exposure	nor	was	 there	any	statistically	significant	difference	when	compared	 to	 the	
control	situation	(Table	8).
			The	cytokine	and	NO	levels	in	NAL	of	samples	taken	after	at	least	one	week	vacation	






(i.e.	 PVC	 flooring	 and	 control).	 No	 changes	 in	 the	 proportions	 of	 lymphocytes,	


















































high	 reproducibility	 of	 a	 single	 determination	 of	 FE
NO




























and	no	drift	 in	 the	 values	was	 found.	Thus,	 the	 intraday	 changes	 in	 the	 nitric	 oxide	
levels	 are	 interpreted	 as	normal	physiological	variation.	 In	 contrast	with	our	 results,	






impact	 on	 the	 physiological	NO	production	 in	 the	 lower	 airways.	This	 is	 of	 special	
interest,	since	cold	air	has	been	reported	to	be	associated	with	inflammatory	cell	leakage	
into	 bronchial	mucosa	 after	 exercise,	 but	 changes	 in	NO	 levels	 have	 not	 supported	
the	presence	of	active	inflammation	(Bonsignore	et	al.	2003).	It	must	be	noted	that	in	
Finland	temperature	and	humidity	varies	extensively	between	the	seasons.		According	





























Henriksen	 et	 al.	 (1999)	 did	 not	 find	 any	 elevation	 in	 FN
NO
	 levels	 during	 the	 pollen	





































































indicate	 that	 inflammatory	 changes	 in	 lower	 airways	 had	 been	 induced	 by	 mould	
challenge.	A. fumigatus	has	been	reported	to	stimulate	NO	production	in	rat	alveolar	
macrophages	(Green	et	al.	1999).	The	results	of	this	thesis	are	also	in	line	with	a	study	
reporting	 increased	NO	 concentrations	 in	NAL	 in	 subjects	with	 occupational	mould	
exposure	 (Hirvonen	 et	 al.	 1999).	 This	 is	 of	 interest	 because	 increased	 FE
NO
	 levels	
are	 associated	with	 inflammatory	 lung	diseases	 such	 as	 asthma	 and	 respiratory	 tract	
infections	 (Kharitonov	 et	 al.	 1994;	Ricciardolo	 2003).	 In	 addition,	 a	 previous	 study	




	 	 	 Baseline	 FE
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this	 thesis	 it	 has	 been	 noted	 that	 an	 experimental	A. fumigatus	 challenge	 can	 cause	
a	 rapid	 increase	 in	FE
NO
	 levels.	Thus,	 it	can	be	proposed	 that	A. fumigatus exposure	
activates	IL-1β	production	which	is	involved	in	the	pathway	leading	to	inflammation	in	
the	upper	airways.
	 	 	TNF-α	 levels	 	 increased	 significantly	 at	 6	 hours	 after	 the	A. fumigatus challenge	
compared	to	placebo	inhalation	also	in	the	control	subjects	but	no	significant	responses	
were	 seen	 in	 all	 the	 subjects	 or	 in	 the	 other	 subgroups.	The	 elevated	TNF-α	 levels	
were	found	to	parallel	to	the	increased	IL-1β	concentrations	since	both	cytokines	are	
proinflammatory	 and	 are	 activated	 as	 a	part	 of	 the	 immune	 response	 against	 stimuli	
such	 as	microbial	 infections	 (Sedgwick	 et	 al.	 2002).	 In	 addition,	 IL-1β	 is	 known	 to	
promote	 the	 production	 of	TNF-α	 (Yoshimura	 et	 al.	 2003).	 In	 accordance	with	 this	
study,	elevated	TNF-α	concentrations	in	NAL	have	been	observed	in	association	with	
microbial	 exposure	 in	 a	moisture-damaged	 building	 (Purokivi	 et	 al.	 2001)	 and	 after	
exposure	to	swine	dust	(Wang	et	al.	1997).
			The	IL-6	levels	in	NAL	of	all	the	subjects	tended	to	be	higher	after	the	A. fumigatus	
challenge	 in	 comparison	 to	placebo	but	no	 significant	differences	were	 found	 in	 the	

















type	 response,	 including	 the	elevated	 IL-4	 levels	dominates	 the	 immune	 response	 in	
A. fumigatus	 induced	 diseases	 such	 as	 pulmonary	 aspergillosis	 (Schuh	 et	 al.	 2003).	
The	changes	in	IL-4	levels	after	the	A. fumigatus challenge	were	most	distinct	in	the	
occupants	of	the	moisture-damaged	building.	Therefore,	inflammation	caused	by	acute	










	 	 	 In	 study	 III,	 there	were	 differences	 between	 the	 groups	 in	 the	measured	 baseline	




study	 that	 there	may	be	considerable	differences	 in	cytokine	baseline	 levels	 in	NAL	
even	between	healthy	individuals	(Roponen	et	al.	2003).	It	can	also	be	assumed	that	the	
anatomy	of	each	subject's	nasal	cavity	may	contribute	to	the	between-subject	variability,	
since	 the	 same	volume	of	 the	 instilled	 fluid	may	 lavage	 a	different	 total	 area	of	 the	
nasal	 cavity	 in	different	 individuals.	However,	because	of	 the	 small	group	 sizes,	 the	
differences	in	cytokine	baseline	levels	before	the	first	challenge	are	not	comparable.
			In	study	III,	the	cytokine	concentrations	in	NAL	decreased	at	6	hours	after	the	placebo	
challenge	and	 returned	at	24	hours	 towards	 the	 level	which	had	been	present	before	
the	 challenge.	 In	 addition,	 there	was	 only	 a	 slight	 increase	 in	 the	 detected	 cytokine	
concentrations	after	the	A. fumigatus	inhalation	at	6	hours	possibly	due	to	an	attenuation	




there	may	 be	 a	major	 variation	 between	 individuals	 and	 genders.	 Baseline	 cytokine	







































	 	 	 In	 line	 with	 the	 increased	 FE
NO




















fungal	 specific	 IgG	antibodies	 (Patovirta	 et	 al.	 2003).	 In	 a	Finnish	population-based	
incident	case-control	study	an	 increased	risk	of	developing	asthma	 in	adulthood	was	
significantly	related	to	IgG	antibodies	to	T. citrinoviride,	but	not	to	the	other	moulds	
including	 A. fumigatus,	 A. versicolor,	 Cladosporium cladosporioides,	 Fusarium 


















	 	 	Mycotoxins	 secreted	by	A. fumigatus	 could	have	potentially	caused	 inflammatory	


















	 	 	The	PVC	and	control	 test	were	performed	blindly	and	 in	a	 random	order	but	 it	 is	






































The	 timing	of	 the	NAL	samplings	was	not	 entirely	optimal	because	on	 the	morning	



































and,	 thus,	 they	 are	 widely	 measured	 in	 clinical	 work	 (ATS/ERS	 2005).	 Inhaled	
corticosteroids	 decline	 FE
NO	



































































	 	 	3.	A. fumigatus	challenge	causes	 inflammation	 in	 the	upper	airways	which	can	be	
detected	 as	 increased	 cytokine	 levels	 in	NAL	with	 the	most	 distinct	 response	 being	
seen	in	IL-1β	levels.	These	results	provide	a	link	between	acute	mould	exposure	and	
biochemical	markers	of	inflammation.
	 	 	 4.	Minuscule	 emissions	 of	 degraded	PVC	 flooring	materials	 that	 can	 be	 detected	
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